Literature DB >> 7407144

A re-evaluation of the surface complexity of the intact erythrocyte.

S Thompson, C M Rennie, A H Maddy.   

Abstract

Surface proteins and glycoproteins of intact human red blood cells were labelled with 125I by the lactoperoxidase method. The radioactive proteins were then separated in each of the Fairbanks and Laemmli one-dimensional polyacrylamide gel electrophoresis systems. The radioactive polypeptides had different mobilities in the two systems, largely due to the anomalous migration of glycoproteins in polyacrylamide gels. A two-dimensional system was therefore developed using the Fairbanks and Laemmli buffer systems to exploit these anomalies. This procedure clearly resolved radioactive glycoproteins and proteins and enabled the identification of many more surface components than had previously proved possible.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7407144     DOI: 10.1016/0005-2736(80)90478-2

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  4 in total

1.  Surface glycoproteins as markers of the cellular status of B chronic lymphocytic leukaemia lymphocytes.

Authors:  V A Brown; S K Smith; A E Dewar; G Stockdill; A H Maddy
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

2.  Detection of erythrocyte membrane proteins, sialoglycoproteins, and lipids in the same polyacrylamide gel using a double-staining technique.

Authors:  J K Dzandu; M E Deh; D L Barratt; G E Wise
Journal:  Proc Natl Acad Sci U S A       Date:  1984-03       Impact factor: 11.205

3.  High resolution two-dimensional gel electrophoresis of human erythrocyte membrane proteins.

Authors:  B R Copeland; S A Todd; C E Furlong
Journal:  Am J Hum Genet       Date:  1982-01       Impact factor: 11.025

Review 4.  Partial purification and characterization of an actin-bundling protein, band 4.9, from human erythrocytes.

Authors:  D L Siegel; D Branton
Journal:  J Cell Biol       Date:  1985-03       Impact factor: 10.539

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.